Dr. Wilbur Lam Receives 2019 Frank A. Oski Memorial Lectureship at the American Society of Pediatric Hematology/Oncology Conference


Prestigious honor presented annually to an accomplished clinical or research scientist

ATLANTA (May 1, 2019) –Wilbur Lam, MD, PhD, a pediatric hematologist/oncologist and biomedical engineer at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, has been chosen to receive the American Society of Pediatric Hematology/Oncology (ASPHO) 2019 Frank A. Oski Memorial Lectureship. He will present at the annual conference on Thursday, May 2.

The Frank A. Oski Memorial Lectureship is awarded annually to an accomplished clinical or research scientist with an MD, PhD or MD/PhD degree. Dr. Lam and his lab have developed innovative microchip-based technologies to study blood diseases as well as devices for diagnostic use outside of the usual clinical settings, including smartphone attachments for remote diagnosis of disease, a point-of-care diagnostic for measuring hemoglobin levels with a single drop of capillary blood and a smartphone app that non-invasively detects anemia. In addition, he has co-founded two startup companies for which he serves as Chief Medical Officer. Dr. Lam currently holds nine patents and has four additional patents pending.

“I am honored and humbled to receive the 2019 Frank A. Oski Memorial Lectureship,” said Dr. Lam. “This was only possible because of the unwavering support of my colleagues and my incredible lab team. Our priority is to keep learning, researching and innovating to make a positive difference in the lives of children and adolescents with hematologic disorders.”

Dr. Lam was selected, in part, for his “basement-to-bench-to-bedside” approach in which the invention, development and clinical translation of new diagnostic and therapeutic micro/nanotechnologies takes place under one scientific roof. The ASPHO Conference brings together over 1,100 pediatric hematology/oncology specialists from the U.S. and across the globe. Founded in 1981, the ASPHO advances research, education, treatment, and professional practice in support of pediatric hematology/oncology professionals, including more than 2,000 members dedicated to the optimal care of children, adolescents and young adults with blood disorders and cancer.

Dr. Lam will present Development and Clinical Translation of Engineered Microsystems for Hematologic Applications on Thursday, May 2, from 2:15-3:00 p.m. during the conference. For more information about Dr. Lam’s presentation or the Aflac Cancer Center, stop by booth #314.

For more information:

Allyson Wright

Senior Public Relations Coordinator

404-785-7253

Allyson.Wright2@choa.org

Aflac Cancer and Blood Disorders Center of Children’s

The Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta is a national leader among childhood cancer, hematology, and blood and marrow transplant programs, serving children and young adults. Recognized as one of the top childhood cancer centers in the country by U.S. News & World Report, the Aflac Cancer Center cares for more than 450 newly diagnosed cancer patients each year and follows more than 3,200 patients with sickle cell disease, hemophilia and other blood disorders. The Center has a well-developed clinical research office and a robust Phase I/II clinical trials infrastructure. Visit aflaccancercenter.org or call 404-785-1112 or 888-785-1112 for more information.

* Required fields

$( document ).ready(function() { addthis.init(); });